Los puntos clave no están disponibles para este artículo en este momento.
Microplastics and nanoplastics (MNPs) are emerging as a potential risk factor for cardiovascular disease in preclinical studies. Direct evidence that this risk extends to humans is lacking.
Marfella et al. (Wed,) studied this question.